1-2 of 2
Thirachit Chotsampancharoen, MD
Close
Sort by
Journal Articles

PETIT and PETIT 2: Treatment with Eltrombopag in 171 Children with Chronic Immune Thrombocytopenia (ITP)

James B. Bussel, MD, John D. Grainger, MD BMBch, MRCP, FRCPATH, Purificacion Garcia de Miguel, Jenny M. Despotovic, DO, MS, Franco Locatelli, Thirachit Chotsampancharoen, MD, Elena K. Donyush, Julian Sevilla Navarro, MD, Bunchoo Pongtanakul, MD, Patcharee Komvilaisak, MD, Darintr Sosothikul, MD, Victor S. Blanchette, MD FRCPC, Guillermo I. Drelichman, MD, Lakshmanan Krishnamurti, MD, Nongnuch Sirachainan, MD, Philip Connor, MD, Michele David, MD FRCPC, Susanne Holzhauer, MD MSc, Vladimir Lebedev, Richard S. Lemons, MD PhD, Dagmar Pospisilova, MD PhD, Ugo Ramenghi, MD, Koh B. Boayue, MD, Dana C. Matthews, MD, Lisa M. Marcello, BA, MS, Malini Iyengar, PhD, Geoffrey W. Chan, MD, Karen D. Chagin, MD, Dickens Theodore, MD MPH, Kalpana K. Bakshi, BS, MS, Christine K. Bailey, PhD
Journal: Blood
Blood (2014) 124 (21): 1450.
https://doi.org/10.1182/blood.V124.21.1450.1450
Published: 2014
Journal Articles

Interim Safety and Effectiveness Results From a 5-Year Observational Study of Deferasirox in Pediatric Patients Aged 2–<6 Years At Enrollment.

Elliott Vichinsky, MD, Amal El-Beshlawy, MD, Azzam Alzoebie, MD, Francoise Bernaudin, MD, Suzanne Koussa, MD, Thirachit Chotsampancharoen, MD, Ali El-Ali, MD, Caroline Arrowsmith, Nicolas Martin, MS, Mohsen El-Alfy, MD
Journal: Blood
Blood (2012) 120 (21): 2125.
https://doi.org/10.1182/blood.V120.21.2125.2125
Published: 2012